Cargando…

Overlap in drug-disease associations between clinical practice guidelines and drug structured product label indications

BACKGROUND: Clinical practice guidelines (CPGs) recommend pharmacologic treatments for clinical conditions, and drug structured product labels (SPLs) summarize approved treatment indications. Both resources are intended to promote evidence-based medical practices and guide clinicians’ prescribing de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leung, Tiffany I., Dumontier, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898307/ https://www.ncbi.nlm.nih.gov/pubmed/27277160 http://dx.doi.org/10.1186/s13326-016-0081-1

Ejemplares similares

Automating Identification of Multiple Chronic Conditions in Clinical Practice Guidelines
por: Leung, Tiffany I., et al.
Publicado: (2015)

InContext: curation of medical context for drug indications
por: Moodley, Kody, et al.
Publicado: (2021)

Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
por: Li, Guangyao, et al.
Publicado: (2022)

Overlap matrix completion for predicting drug-associated indications
por: Yang, Mengyun, et al.
Publicado: (2019)

Formalizing drug indications on the road to therapeutic intent
por: Nelson, Stuart J, et al.
Publicado: (2017)

Discovering associations between adverse drug events using pattern structures and ontologies
por: Personeni, Gabin, et al.
Publicado: (2017)

High-Risk Drug–Drug Interactions Between Clinical Practice Guidelines for Management of Chronic Conditions
por: Tso, Geoffrey J., et al.
Publicado: (2017)

Authors’ Response to Peer Reviews of “Representing Physician Suicide Claims as Nanopublications: Proof-of-Concept Study Creating Claim Networks”
por: Leung, Tiffany I, et al.
Publicado: (2022)

Representing Physician Suicide Claims as Nanopublications: Proof-of-Concept Study Creating Claim Networks
por: Leung, Tiffany I, et al.
Publicado: (2022)

Recommendations on Off-Label Drug Use in Pediatric Guidelines
por: Meng, Min, et al.
Publicado: (2022)

Pharmacogenetic Guidelines for Psychotropic Drugs: Optimizing Prescriptions in Clinical Practice
por: Baldacci, Antoine, et al.
Publicado: (2023)

Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI)
por: Brennan, Paul N, et al.
Publicado: (2021)

Ranking Adverse Drug Reactions With Crowdsourcing
por: Gottlieb, Assaf, et al.
Publicado: (2015)

Drug–drug interaction extraction via hierarchical RNNs on sequence and shortest dependency paths
por: Zhang, Yijia, et al.
Publicado: (2018)

Evaluation of knowledge graph embedding approaches for drug-drug interaction prediction in realistic settings
por: Celebi, Remzi, et al.
Publicado: (2019)

Drug-Drug Interaction Data Source Survey and Linking
por: Ayvaz, Serkan, et al.
Publicado: (2014)

Clarity and applicability of adverse drug reaction-related monitoring instructions in clinical practice guidelines for children and adolescents treated with antipsychotic drugs: a review of six clinical practice guidelines
por: Minjon, Lenneke, et al.
Publicado: (2022)

Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
por: WANG, Weilan, et al.
Publicado: (2013)

Evaluation of Current Regulation and Guidelines of Pharmacogenomic Drug Labels: Opportunities for Improvements
por: Shekhani, Rawan, et al.
Publicado: (2019)

Guideline for the management of pediatric off-label use of drugs in China (2021)
por: Meng, Min, et al.
Publicado: (2022)

Use of Drugs for Off-Label Indications: Living in the Same World
por: Barbuto, John P.
Publicado: (2003)

Laparoscopic hysterectomy for benign indications: clinical practice guideline
por: Sandberg, Evelien M., et al.
Publicado: (2017)

A dataset of 200 structured product labels annotated for adverse drug reactions
por: Demner-Fushman, Dina, et al.
Publicado: (2018)

Clinical practice guidelines for translating pharmacogenomic knowledge to bedside. Focus on anticancer drugs
por: Agúndez, José A. G., et al.
Publicado: (2014)

Gastrointestinal Bleeding and Anticoagulant or Antiplatelet Drugs: Systematic Search for Clinical Practice Guidelines
por: Gutermann, Irit Kaye, et al.
Publicado: (2015)

Applicability of somatic monitoring instructions in clinical practice guidelines on antipsychotic drug use
por: Brouwer, Jurriaan M. J. L., et al.
Publicado: (2021)

Pharmacogenomic information from CPIC and DPWG guidelines and its application on drug labels
por: Yoon, Deok Yong, et al.
Publicado: (2020)

Dynamic enhancement of drug product labels to support drug safety, efficacy, and effectiveness
por: Boyce, Richard D, et al.
Publicado: (2013)

Scandinavian clinical practice guideline on fluid and drug therapy in adults with acute respiratory distress syndrome
por: Claesson, J., et al.
Publicado: (2016)

Assessing the Quality of Existing Clinical Practice Guidelines for Chemotherapy Drug Extravasation by Appraisal of Guidelines for Research and Evaluation II
por: Bahrami, Masoud, et al.
Publicado: (2019)

Interactome overlap between risk genes of epilepsy and targets of anti-epileptic drugs
por: Lv, Yu-Qin, et al.
Publicado: (2022)

Zolpidem prescribing practices before and after Food and Drug Administration required product labeling changes
por: Norman, Jessica L, et al.
Publicado: (2017)

Outcomes of stenting with overlapping drug-eluting stents versus overlapping drug-eluting and bare-metal stents for the treatment of diffuse coronary lesions
por: Kassaian, SE, et al.
Publicado: (2010)

Provision of guideline-based care for drug-resistant tuberculosis in South Africa: Level of concordance between prescribing practices and guidelines
por: van de Water, Brittney J., et al.
Publicado: (2018)

Clinical practice guideline for drug-induced kidney injury in Japan 2016: digest version
por: Usui, Joichi, et al.
Publicado: (2016)

Guideline-based quality indicators—a systematic comparison of German and international clinical practice guidelines
por: Becker, Monika, et al.
Publicado: (2019)

Challenges and guidelines for clinical trial of herbal drugs
por: Parveen, Abida, et al.
Publicado: (2015)

Guidelines for clinical evaluation of anti‐cancer drugs
por: Minami, Hironobu, et al.
Publicado: (2021)

Integration of Ligand-Based Drug Screening with Structure-Based Drug Screening by Combining Maximum Volume Overlapping Score with Ligand Doscking
por: Fukunishi, Yoshifumi, et al.
Publicado: (2012)

Predicting the need for a reduced drug dose, at first prescription
por: Coulet, Adrien, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c94o9qau21fnvbedptffve33pf